M2N12 |
A clickable Cdc25 inhibitor (IC50s = 0.53, 1.39, and 0.09 µM for Cdc… |
10 mg |
37391-10 |
More Info
|
M2N12 |
A clickable Cdc25 inhibitor (IC50s = 0.53, 1.39, and 0.09 µM for Cdc… |
5 mg |
37391-5 |
More Info
|
MN-001 |
An anti-inflammatory agent; reduces the frequency of bladder voids, increa… |
1 mg |
11948-1 |
More Info
|
MN-001 |
An anti-inflammatory agent; reduces the frequency of bladder voids, increa… |
5 mg |
11948-5 |
More Info
|
MN-001 |
An anti-inflammatory agent; reduces the frequency of bladder voids, increa… |
500 µg |
11948-500 |
More Info
|
MN-18 |
A synthetic CB modeled after AKB48, with the adamantyl group replaced by a… |
1 mg |
14817-1 |
More Info
|
MN-18 |
A synthetic CB modeled after AKB48, with the adamantyl group replaced by a… |
10 mg |
14817-10 |
More Info
|
MN-18 |
A synthetic CB modeled after AKB48, with the adamantyl group replaced by a… |
5 mg |
14817-5 |
More Info
|
MN-25 |
An analytical reference standard categorized as a synthetic cannabinoid; i… |
1 mg |
14249-1 |
More Info
|
MN-25 |
An analytical reference standard categorized as a synthetic cannabinoid; i… |
10 mg |
14249-10 |
More Info
|
MN-25 |
An analytical reference standard categorized as a synthetic cannabinoid; i… |
5 mg |
14249-5 |
More Info
|
MN-64 |
A potent inhibitor of TNKS1 and TNKS2 (IC50s = 6 and 72 nM, respectively);… |
1 mg |
17635-1 |
More Info
|
MN-64 |
A potent inhibitor of TNKS1 and TNKS2 (IC50s = 6 and 72 nM, respectively);… |
10 mg |
17635-10 |
More Info
|
MN-64 |
A potent inhibitor of TNKS1 and TNKS2 (IC50s = 6 and 72 nM, respectively);… |
25 mg |
17635-25 |
More Info
|
MN-64 |
A potent inhibitor of TNKS1 and TNKS2 (IC50s = 6 and 72 nM, respectively);… |
5 mg |
17635-5 |
More Info
|
MNI-caged-L-glutamate (trifluoroacetate salt) |
A form of glutamate linked to a photoprotecting that upon exposure to ligh… |
1 mg |
19532-1 |
More Info
|
MNI-caged-L-glutamate (trifluoroacetate salt) |
A form of glutamate linked to a photoprotecting that upon exposure to ligh… |
10 mg |
19532-10 |
More Info
|
MNI-caged-L-glutamate (trifluoroacetate salt) |
A form of glutamate linked to a photoprotecting that upon exposure to ligh… |
25 mg |
19532-25 |
More Info
|
MNI-caged-L-glutamate (trifluoroacetate salt) |
A form of glutamate linked to a photoprotecting that upon exposure to ligh… |
5 mg |
19532-5 |
More Info
|
Mn(III) Protoporphyrin IX Chloride |
A metalloporphyrin; induces mRNA expression of the genes encoding δ-… |
100 mg |
30808-100 |
More Info
|
Mn(III) Protoporphyrin IX Chloride |
A metalloporphyrin; induces mRNA expression of the genes encoding δ-… |
250 mg |
30808-250 |
More Info
|
Mn(III) Protoporphyrin IX Chloride |
A metalloporphyrin; induces mRNA expression of the genes encoding δ-… |
50 mg |
30808-50 |
More Info
|
Mn(III) Protoporphyrin IX Chloride |
A metalloporphyrin; induces mRNA expression of the genes encoding δ-… |
500 mg |
30808-500 |
More Info
|
Mn(III)TBAP (chloride) |
Mn(III)TBAP is a cell-permeable SOD mimic. At a concentration of 30 µ… |
10 mg |
75850-10 |
More Info
|
Mn(III)TBAP (chloride) |
Mn(III)TBAP is a cell-permeable SOD mimic. At a concentration of 30 µ… |
100 mg |
75850-100 |
More Info
|
Mn(III)TBAP (chloride) |
Mn(III)TBAP is a cell-permeable SOD mimic. At a concentration of 30 µ… |
25 mg |
75850-25 |
More Info
|
Mn(III)TBAP (chloride) |
Mn(III)TBAP is a cell-permeable SOD mimic. At a concentration of 30 µ… |
50 mg |
75850-50 |
More Info
|
Mn(III)TMPyP |
Mn(III)TMPyP is a cell-permeable SOD mimic and peroxynitrite decomposition… |
10 mg |
75852-10 |
More Info
|
Mn(III)TMPyP |
Mn(III)TMPyP is a cell-permeable SOD mimic and peroxynitrite decomposition… |
100 mg |
75852-100 |
More Info
|
Mn(III)TMPyP |
Mn(III)TMPyP is a cell-permeable SOD mimic and peroxynitrite decomposition… |
25 mg |
75852-25 |
More Info
|
Mn(III)TMPyP |
Mn(III)TMPyP is a cell-permeable SOD mimic and peroxynitrite decomposition… |
50 mg |
75852-50 |
More Info
|
MN-25-2-methyl derivative |
A CB receptor ligand with Ki values of 8 and 29 nM at CB1 and CB2 receptor… |
1 mg |
9001455-1 |
More Info
|
MN-25-2-methyl derivative |
A CB receptor ligand with Ki values of 8 and 29 nM at CB1 and CB2 receptor… |
10 mg |
9001455-10 |
More Info
|
MN-25-2-methyl derivative |
A CB receptor ligand with Ki values of 8 and 29 nM at CB1 and CB2 receptor… |
5 mg |
9001455-5 |
More Info
|
MN-18 N-(5-hydroxypentyl) metabolite |
An analytical reference standard categorized as a synthetic cannabinoid me… |
1 mg |
35278-1 |
More Info
|
MNS |
Blocks and reverses platelet aggregation induced by such triggers as colla… |
10 mg |
15206-10 |
More Info
|
MNS |
Blocks and reverses platelet aggregation induced by such triggers as colla… |
100 mg |
15206-100 |
More Info
|
MNS |
Blocks and reverses platelet aggregation induced by such triggers as colla… |
50 mg |
15206-50 |
More Info
|
MNS |
Blocks and reverses platelet aggregation induced by such triggers as colla… |
500 mg |
15206-500 |
More Info
|
Mobocertinib |
An inhibitor of mutant EGFR and HER2 receptors; selective for HER2V659E, H… |
1 mg |
31522-1 |
More Info
|
Mobocertinib |
An inhibitor of mutant EGFR and HER2 receptors; selective for HER2V659E, H… |
10 mg |
31522-10 |
More Info
|
Mobocertinib |
An inhibitor of mutant EGFR and HER2 receptors; selective for HER2V659E, H… |
25 mg |
31522-25 |
More Info
|
Mobocertinib |
An inhibitor of mutant EGFR and HER2 receptors; selective for HER2V659E, H… |
5 mg |
31522-5 |
More Info
|
Mocetinostat |
An orally available HDAC inhibitor that selectively targets HDAC1 and 2 (I… |
1 mg |
18287-1 |
More Info
|
Mocetinostat |
An orally available HDAC inhibitor that selectively targets HDAC1 and 2 (I… |
10 mg |
18287-10 |
More Info
|
Mocetinostat |
An orally available HDAC inhibitor that selectively targets HDAC1 and 2 (I… |
25 mg |
18287-25 |
More Info
|
Mocetinostat |
An orally available HDAC inhibitor that selectively targets HDAC1 and 2 (I… |
5 mg |
18287-5 |
More Info
|
MO-CHMINACA |
A synthetic CB structurally related to AB-CHMINACA in which the carboxamid… |
1 mg |
17136-1 |
More Info
|
MO-CHMINACA |
A synthetic CB structurally related to AB-CHMINACA in which the carboxamid… |
10 mg |
17136-10 |
More Info
|
MO-CHMINACA |
A synthetic CB structurally related to AB-CHMINACA in which the carboxamid… |
5 mg |
17136-5 |
More Info
|